In their landmark study, Grassoet al. compared the exomes of 50 heavily treated metastatic CRPC tumours with 11 high-grade treatment-naïve non-metastatic tumours65, and a number of genes encoding proteins that interact with, and/or regulate the activity of, the AR were found to be altered. The gene discussed is AR; the disease is neoplasm.